MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. (scientific article published on 4 April 2018)

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function

Q28277266

The morphological and molecular nature of synaptic vesicle priming at presynaptic active zones

Q28506683

Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size

Q28513229

Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures

Q28534050

Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes

Q56992446

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

Q46171371

MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD.

Q48118147

Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity

Q48198484

A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity

Q48348498

A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.

Q50015658

Identifying true protein complex constituents in interaction proteomics: the example of the DMXL2 protein complex.

Q54503711

A brain-specific microRNA regulates dendritic spine development

Q29614753

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

Q29616080

limma powers differential expression analyses for RNA-sequencing and microarray studies

Q29617988

Potential Impact of miR-137 and Its Targets in Schizophrenia

Q30454963

MicroRNA-223 is neuroprotective by targeting glutamate receptors

Q30528539

Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.

Q30901756

Cross talk between microRNA and epigenetic regulation in adult neurogenesis

Q33788417

The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects

Q33923604

Transcriptome-wide discovery of microRNA binding sites in human brain.

Q33940022

Properties of synchronous and asynchronous release during pulse train depression in cultured hippocampal neurons

Q33949457

Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans

Q34475541

Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons

Q35038309

MicroRNA regulation of homeostatic synaptic plasticity

Q35105269

Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation

Q35596962

Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons

Q35697823

Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia

Q35761611

miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells

Q35818683

The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins

Q37060125

Gene expression elucidates functional impact of polygenic risk for schizophrenia

Q37372402

Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells

Q37505070

Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells

Q37706529

Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability

Q38331099

The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function.

Q38450466

Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia

Q38883878

Transcriptional targets of the schizophrenia risk gene MIR137.

Q38979078

MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets

Q38989183

Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients

Q40105455

Disruption of the microRNA 137 primary transcript results in early embryonic lethality in mice.

Q42260728

Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets